Aperiomics, Inc., a biotechnology company, provides pathogens detection services to animal screening, agricultural testing, and human diagnostics industry through a combination of genomics and informatics. The company detects viral, bacterial, fungal, and parasite pathogens in a single test. It uses sequencing technologies and advanced Bayesian statistics to provide results. The company allows its customers’ to send blood, tissue, and stool samples to be sequenced, which then is analyzed through a laboratory using a proprietary informatics pipeline. Aperiomics, Inc. was formerly known as NextGen Diagnostics, Inc. and changed its name to Aperiomics, Inc. in July 2014. The company was founded in 2013 and is based in Sterling, Virginia.